Palbociclib|PD0332991|DC Chemicals

Palbociclib|PD0332991|DC Chemicals

Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity.

Product Name: Palbociclib |Catalog Number: DC8469 |CAS 571190-30-2 |Other names: PD0332991; PD-0332991; PD 0332991 |Chemical Name:  |Molecule Formular: C24H29N7O2 |MW: 447.53

Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib is a highly specific inhibitor of cyclindependent kinase 4 (Cdk4) (IC50, 0.011 μmol/L) and Cdk6 (IC50, 0.016 μmol/L), having no activity against a panel of 36 additional protein kinases.

For research and scientific purpose only, not for human use.